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Rift Valley fever (RVF) is endemic in many countries in Sub-Saharan Africa and is
responsible for severe outbreaks in livestock characterized by a sudden onset of abortions
and high neonatal mortality. During the last decade, several outbreaks have occurred in
Southern Africa, with a very limited number of cases reported in Botswana. To date,
published information on the occurrence of RVF in wild and domestic animals from
Botswana is very scarce and outdated, despite being critical to national and regional
disease control. To address this gap, 863 cattle and 150 buffalo sampled at the interface
between livestock areas and the Chobe National Park (CNP) and the Okavango Delta (OD)
were screened for the presence of RVF virus (RVFV) neutralizing antibodies. Antibodies
were detected in 5.7% (n=863), 95% confidence intervals (CI) (4.3–7.5%) of cattle and
12.7% (n=150), 95% CI (7.8–19.5%) of buffalo samples. The overall prevalence was
significantly higher (p=0.0016) for buffalo [12.7%] than for cattle [5.7%]. Equally, when
comparing RVF seroprevalence in both wildlife areas for all pooled bovid species, it was
significantly higher in CNP than in OD (9.5 vs. 4%, respectively; p=0.0004). Our data
provide the first evidence of wide circulation of RVFV in both buffalo and cattle populations
in Northern Botswana and highlight the need for further epidemiological and ecological
investigations on RVF at the wildlife–livestock–human interface in this region.
Keywords: Rift Valley fever, African buffalo, Syncerus caffer, neutralizing antibodies, cattle, serology, one health,
Botswana
INTRODUCTION
Rift Valley fever (RVF) is an emerging zoonotic disease of significant public and animal health
concern (1, 2). The most important mosquito vectors of RVF virus (RVFV) are members of the
subgenera Neomelaniconion (genus Aedes) and Culex (genus Culex) (3). Human infections arise
from contact with infected animal blood and tissues or from vector-mediated transmission (4).
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Human to human transmission has not been reported. Themajor-
ity of human infections is subclinical or associated with mod-
erate to severe, non-fatal, febrile illness, while some patients
can develop a hemorrhagic syndrome and/or ocular and neu-
rological lesions. RVF cases in humans may be clinically indis-
tinguishable from other viral hemorrhagic fevers (VHF), such
as Ebola virus disease, Marburg virus disease, Crimean–Congo
hemorrhagic fever, and Lassa fever (4, 5). In domestic rumi-
nants, RVF occurs as epizootic waves of abortions and deaths
of newborns resulting in significant socioeconomic losses. The
difficulty in preventing the disease lies largely in the long interepi-
demic periods which can be up to 15 years or longer in Eastern
and Southern African (4, 6). RVF outbreaks have been reported
over much of the African continent, Arabian Peninsula, and
were most recently detected in countries from the Indian Ocean
(2, 7, 8). Data on RVFV epidemiology, including its mainte-
nance and dynamics of transmission in Botswana, are to date,
limited.
Rift Valley fever outbreaks have occurred across most of South-
ern Africa (4) with the most recent significant outbreaks occur-
ring in 2010 in South Africa and Namibia (9, 10), with appar-
ent suspected spread into Southern Botswana during that same
period (11). This was the first reported case of RVF infection in
animals in the country. However, serological evidence of RVFV
exposure in humans had been identified in the early 1960s in
the Chobe District (12). In addition in 1986, 27% of a sample of
wildlife hunters residing in Chobe National Park (CNP) (n= 52)
and 3% of a small sample of the population collected across
villages in the same district (n= 77) were found seropositive to
RVFV. During this survey, a limited number of domestic and
wild animals were sampled and tested negative with the indi-
rect immunofluorescence assay, but evidence of RVFV exposure
in animals could not be found (13). Given the significance of
RVF to both human and animal health, this work focused on
evaluating exposure to RVFV among livestock and buffalo pop-
ulations at the livestock–wildlife interface in two major wildlife
areas of Northern Botswana: the Okavango Delta (OD) and
the CNP.
MATERIALS AND METHODS
Study Area
The districts of Northern Botswana (Ngamiland East, Ngami-
land West, and Chobe Disricts) are characterized by large pro-
tected land areas where abundant wildlife and livestock occur
in close seasonal association around the only permanent sources
of surface water in the region, the OD, and the Chobe River.
Botswana has three distinct seasons that strongly influence the
movement of wild and domestic animals: the wet season (Novem-
ber–March), the cool dry season (April–July), and the hot dry
season (August–October). This cyclical variation of rainfall over
the years has strong seasonal effects on the geographic distribution
of biomass (livestock and wildlife combined) with the highest
density of water-dependent animals concentrated near permanent
sources of surface water during the dry season; while during the
wet season, animals disperse across the landscape using ephemeral
sources of water. These seasonal shifts are most pronounced in
and around Chobe District, where the effects of seasonal water
availability on vegetation are most dramatic (14).
The study was conducted in the OD (Ngamiland East and
Ngamiland West Districts) and in the CNP (Chobe District)
during October 2010 and October 2011, respectively (Figure 1).
Both areas encompass the Botswana component of the Kavango
Zambezi Trans Frontier ConservationArea (KAZATFCA),which
connects protected areas from Zambia, Zimbabwe, Namibia, and
Angola. Both wildlife areas are within the Botswana Foot and
Mouth Disease infected area where buffalo and cattle populations
are separated from the primary cattle export regions by buffer
zones where movement of animals and related products is con-
trolled. The Chobe River in the north of the CNP constitutes
the border between Botswana and Namibia. There is no physical
separation between cattle and wildlife in this region. Conversely,
the OD, very rich in wildlife, is separated from livestock areas by
a double veterinary cordon fence (Figure 1) to prevent contact
between buffalo and cattle in the Ngamiland District (15). Buffalo
incursions into livestock zones outside the fence occur occasion-
ally, when the fence is damaged by elephants or floods (16). In
2010, buffalo populations were estimated at 31,500 animals in the
OD and 7500 in CNP (17).
The total cattle population in Northern Botswana is estimated
at 250,000 heads with 2620 cattle occurring in Chobe District and
241,000 cattle in Ngamiland (18). Cattle are mainly indigenous
breeds reared in communal grazing areas. As in many other
countries in Southern Africa (19), livestock herds sharing the
same grazing lands are regularly gathered (approximately twice
a month) at crush pens (e.g., holding facilities) used by the
Botswana animal health authorities to undertake preventive and
control measures for notifiable animal diseases (treatment with
acaricides, surveillance and vaccination). The average number
of cattle in a crush pen can range between 200 and 2000, the
median herd size in northern Botswana being estimated at 35
individuals, interquartile range (19, 64) (16). At the time of the
study, Chobe and the two Ngamiland Districts had six and 36
crush pens located, respectively, <15 km from the protected area
boundaries, which were used as a focus for cattle sampling.
Study Design
In buffalo herds, the sampling process was opportunistic and
depended on herd detection during aerial capture operations (16).
Buffalo sampling was focused along the Chobe River in CNP
(n= 79) and two additional locations inside the OD: the Moremi
Game Reserve (MGR) (n= 35) and the NG30 area (n= 37).
The age of the captured buffalo was estimated from dentition
(20). Animals were categorized as young (<1.5 years), subadult
(1.5–3 years), or adult (older than 3 years (21). Buffalo densities
in these locations were estimated at 1.88 buffalo/km2 along the
Chobe river, 1.37 buffalo/km2 in the MGR, and 3.55 buffalo/km2
for the NG30 area (17).
We assumed seroprevalence of RVF to be 5%, the lowest esti-
mated seroprevalence by the virus neutralization test (VNT) in
buffalo, in other protected areas in Africa (22). In order to esti-
mate seroprevalence with a 90% confidence level and 5% desired
precision, at least 52 animals needed to be sampled per region.We
sampled 60 buffalo per wildlife area.
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FIGURE 1 |Map of the study area showing the locations where buffalo and cattle were sampled in Northern Botswana. The contour of Botswana
highlights the Northern Districts of Chobe (right), Ngamiland East (middle), and Ngamiland West (left).
In both districts, cattle crush pens to be sampled were chosen
according to their proximity to protected area boundaries and the
availability of the National Veterinary Services teams to operate in
the area. In this manner, 10 crush pens were selected in Ngami-
land District and five in Chobe District. Cattle in this region are
regularly vaccinated against FMD, brucellosis, and other diseases
but are not vaccinated against RVF.
Data on cattle numbers at crush pens were not available at
the time of sampling. From previous fieldwork in the study
regions, we estimated cattle numbers at 500 animals per crush
pen. Using an estimated seroprevalence of 5% derived from pre-
vious studies conducted in sub-Saharan Africa (23, 24), at least
48 animals per crush pen would need to be sampled to esti-
mate seroprevalence with a 90% confidence level and a desired
precision of 5%. In the OD interface region, five animals per
herd were sampled while 10 animals per herd were sampled
in the CNP interface (the first animals available from every
herd). With some sample loss due to hemolysis and, at times,
lower than expected crush pen numbers in some locations, we
obtained a final total sample size of 432 cattle in CNP and 456
cattle in OD.
Serological Analysis
Sera were tested for the detection of specific anti-RVFV antibodies
using VNT (25), the gold standard for detection of RVFV neu-
tralizing antibodies. A serum sample was considered seropositive
when it had a titer of log10 1.0, equivalent to a serum dilution
1:10.
Statistical Analysis
Sample sizes were calculated with the use of Epi Tools (http:
//epitools.ausvet.com.au). Descriptive epidemiological measures
were conducted using the software program Epi-Info (CDC,
Atlanta, GA, USA) and were reported as percentages of positive
animals with 95%Clopper–Pearson binomial confidence intervals
(CI). The chi-square test for homogeneity of two populations
was used to evaluate the potential influence of age, sex, and cap-
ture location on the observed seroprevalence in sampled buffalo,
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influence of location in sampled cattle, and species and region in
the total sample. Stratified analyses were conducted to compare
prevalence between species after stratifying by region. Values of
p< 0.05 were considered significant.
Ethics
The study was designed and implemented in collaboration with
the Food and Agricultural Organization-Emergency Centre for
TransboundaryAnimalDiseases (FAO-ECTAD)Office for South-
ern Africa. The project was approved by the highest sanitary
[Department of Veterinary Services (DVS)] and wildlife man-
agement authorities [Department of Wildlife and National Parks
(DWNP)] in Botswana. A scientific permit from the DWNP was
requested and obtained for sampling buffalo. The sampling of
cattle did not require any ethics approval but the project was
discussed, approved by DVS, and undertaken with their direct
collaboration in the field activities. Permits were obtained from
appropriate regulatory authorities for the movement of animal
samples outside the foot and mouth disease infected area to
targeted laboratories.
RESULTS
A total of 150 buffalo (79 from CNP and 71 from OD) and
863 cattle (424 from CNP and 439 from OD) samples were
finally obtained for analysis and interpretation. Results for the
observed prevalence and 95% CI per species and region can
be found in Table 1. The overall prevalence was significantly
higher (p= 0.0016) for buffalo [12.7%, 95% CI (7.8–19.5%)]
than for cattle [5.7%, 95% CI (4.3–7.5%)]. When comparing
RVF seroprevalence in both wildlife areas for all pooled bovid
species, seroprevalence was significantly higher in CNP than
in OD (9.5 vs. 4%, respectively; p= 0.0004). Stratified analysis
of the effect of species after adjusting for region provided that
differences in prevalence between species were only marginally
significant in CNP (p= 0.057) but highly significant in the OD
(p= 0.005).
Buffalo
Buffalo were sampled from 15 different herds. The herd size
varied widely ranging between bachelor groups of five individ-
uals to megaherds (e.g., temporal aggregation of several sub-
herds potentially reaching more than 1500 individuals). Among
the sampled buffalo of known age, 10.5% (n= 144) were young
animals (1.5 years or younger), 28% (n= 144) were subadults
(1.5–3 years), and 62% (n= 144) were adults (older than 3 years).
The median estimated age of the sampled population was 5 years
(2–9). Among animals sampled, 59% were female and 37% were
male. For a limited number of individuals, age or sex data were not
available (seven and five individuals, respectively). These samples
were excluded from analyses of sex or age. Neutralizing antibodies
against RVFVwere detected in 10 out of the 15 herds sampledwith
values ranging between 6 and 29%. The overall prevalence in buf-
faloes was [12.7%, 95% CI (7.8–19.1%)] with 84% of those having
titers 1/40 (n= 19). The median age of positive buffaloes was
6.5 years (5–8). Seroprevalence was higher in animals captured
in the CNP than OD, but those differences were not statistically
significant. Similarly, no significant differences in seroprevalence
levels were detected by age class, capture site, or sex (Table 1).
Cattle
Among the seropositive cattle, 75% (n= 49) had titers higher than
1/40. In those animals sampled in OD, five out of 10 crush pens
showed detectable neutralizing antibodies at prevalence rang-
ing between 2.1 and 11.6%, while in the CNP, four out of five
crush pens detected positive animals, with seroprevalence values
ranging between 5.2 and 17.8% (Table 1). Seroprevalence was
significantly higher in cattle sampled at the interface with CNP
compared to cattle sampled at the OD periphery (p= 0.004, 9.5
vs. 3.9%; Table 1).
DISCUSSION
We report the first large-scale RVFV seroprevalence study in
African buffalo and domestic cattle in Botswana. We identified
TABLE 1 | Occurrence of RVF antibodies per species and region (and age, sex, and capture site in the case of buffalo) based on VN test results expressed
in prevalence, ratio and 95% confidence intervals (CI).
Species Variable Category Prevalence (%), ratio, and
95% confidence interval
p value
Cattle Location Chobe National Park 8.5 (36/424) [6.1–11.7] 0.004
Okavango Delta 2.96 (13/439) [1.65–5.1]
Buffalo Location Chobe National Park 15.38 (12/78) [8.21–25.33] 0.29
Okavango Delta 9.72 (7/72) [4.00–19.01]
Age Subadulta 9.90 (5/54) [3.08–20.3] 0.07
Adultb 13.48 (12/89) [7.25–22.61]
Sex Female 10.1 (9/89) [4.73–18.33] 0.45
Male 14.3 (8/56) [6.38–26.22]
Capture site Chobe River 15.38 (12/78) [8.21–25.33]
Moremi Game Reserve 8.57 (3.35) [11.0–26.3] 0.5
NG 30 10.81 (4/37) [3.0–25.4]
Overall 6.71 (68/1013) [5.29–8.48]
a3 years or younger.
bOlder than 3 years.
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the presence of neutralizing antibodies to RVFV in both species
in the absence of reported clinical disease at the time of sampling
(October 2010 and 2011). Silent circulation of RVFV has been
described elsewhere in sub-Saharan Africa (6) and suggests that
in some locations, the virus may circulate for decades, in the
absence of reported outbreaks or identification of clinical cases
in humans or animals. Levels of antibodies detected in buffalo
samples (13%) were considerably higher when compared with
those reported in other studies in South Africa [5.8%; n= 928
(26), 7.5%; n= 1023 (27), and 21/1%; n= 66 (28)] and similar
to the ones reported during an interepidemic period in Kenya
[15.6%; n= 237 (22)].
In cattle, seroprevalence levels were significantly lower than
those observed in buffalo, but results were difficult to compare
because VNT surveys in cattle are scarce in the literature. Using
the VNT to evaluate RVF seroprevalence in cattle in Burkina
Faso, Boussini et al. (23) reported an overall prevalence of 11.8%
(n= 40), but results per herd or area were not provided. Simi-
larly, the sample size in our study was insufficient to determine
RVFV exposure status at a herd level and, therefore, only regional
prevalence values are provided.
The VNT is a highly accurate test with little or no cross-
neutralization with other phleboviruses (29), and it is regarded
as the gold standard for RVF serology. Nevertheless, it is labo-
rious, expensive, and since it requires live virus, can only be
implemented in suitable biocontainment facilities. Neutralizing
antibodies detected by the VNT are life long and therefore,
seropositive status does not provide insight into exposure period
(29). The age of sampled cattle was not recorded in our study,
limiting our ability to evaluate how recently the animals might
have been exposed to RVFV. In the case of buffalo, our sample
was biased towards adult individuals (59.3% of sampled animals)
and only five subadult individuals (3 years or younger) were found
seropositive. The youngest seropositive animals detected were
1.5 years (n= 2), indicating that the most recent exposure to virus
likely occurred <2 years before the animals were sampled. In
addition, the median age of positive buffalo was quite high and
could partially explain the high levels of antibodies observed in
our buffalo sample.
Our findings provide evidence that RVFV is actively circulating
at the domestic and wild bovid species at the wildlife–livestock
interface in the absence of other reported disease outbreaks or
clinical cases. The only exception is a recent confirmed case of
RVFV infection presenting abortions in two cows from a farm
in the Chobe District (30). This case occurred in the same cattle
area where our survey was conducted. In the context of our
findings, this single case report suggests that clinical disease
may be occurring at higher levels than suspected. This seems to
be further supported by the fact that nearly one-third of small
scale cattle farmers interviewed in Northern Botswana at the
time of this study (16) reported the occurrence of abortions in
their herds in the preceding year (31.2%, n= 135). Although
abortions can be induced by a diversity of pathogens, these data
suggest that cattle abortions are common, but often underre-
ported or not investigated at all, due to the extensive produc-
tion systems prevalent in the study area and the absence of
systematic reproductive monitoring in cattle among small scale
farmers. Similarly, human cases in local clinics may easily go
undetected or possibly misdiagnosed with other common infec-
tious diseases presenting with acute febrile symptoms, such as
malaria (31).
Our survey results indicate non-negligible prevalence values
in both study areas which are separated by 370 km, suggesting
that the presence of RVF is likely to be widespread in North-
ern Botswana. Seroprevalence values were significantly higher in
domestic and wild animals from the Chobe District than in those
living inside or surrounding the OD. The fact that the sampling
effort ended up being more intense in the CNP interface than
in the OD interface (sample sizes were similar but populations
of buffalo and cattle are significantly higher in the OD) could
partially explain the differences in regional prevalence estimates.
However, there are also ecological differences that could affect
the dynamics of vectors, hosts, and disease presence. Each of
these hydrological systems is exposed to different environmental
and climatic influences regulating water levels which can affect
mosquito hatching and survival in different ways. In the OD, for
instance, large water surfaces are available all year round in the
inland delta. In the CNP, water availability is localized in a river
floodplain system, which can have an impact in the aggregation
patterns of domestic andwild hosts around the banks of theChobe
River during the dry season. Our data further suggest that, as
shown in other parts of Southern Africa (28), buffalo might be
important as a natural host playing a role in the amplification of
RVFV in Northern Botswana. Other wildlife species may also be
involved and act as amplification hosts (22, 25, 32, 33). However,
the full spectrum of wild and domestic host involvement and
their contribution to the virus circulation in Northern Botswana
is presently unknown.
Weather conditions are known to affect the dynamics and
intensity of RVF outbreaks through influence on both vector and
host population dynamics and viral transmission. In the 1986
human survey (13), a higher seroprevalence of anti-RVFV anti-
bodies was detected in December after the onset of heavy rains.
Equally, the abortion cases reported in 2014were detected in April
most likely resulting from an infection during the rainy season
suggesting that the virus could be more active during the first
months of the year and could circulate periodically during the
rainy season.
Little information is available regarding the spatial and tem-
poral dynamics of RVFV circulation in Southern Africa at
the wildlife–livestock–human interface. Buffalo populations in
Botswana within the boundaries of the KAZA TFCA are poten-
tially connected, allowing movement of the virus through larger
landscapes. Molecular epidemiological investigations will be
needed to provide insight into the spatial and temporal dynamics
of transmission and persistence for this important animal and
public health threat.
CONCLUSION
Our results provide evidence that RVFV circulates actively in
both wild and domestic bovids in two different areas of North-
ern Botswana. This raises concern of the potential exposure of
RVFV in humans in the region and the need to consider the
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possible occurrence of RVF infection in acute febrile and/or hem-
orrhagic conditions. Similarly, clinical cases in domestic animals
may be more common than currently reported, raising the need
for increased public awareness on the importance of reporting
abortions in livestock. Particular attention should be given to the
occurrence of such cases after the onset of heavy rains. Further
studies are needed to characterize RVF circulating virus in these
endemic settings and investigate the temporal and spatial epi-
demiological dynamics of virus transmission and circulation at
the human, domestic, and wild animal compartments. As RVFV
spillover to humans can occur through vector transmission as well
as direct contact with infected animal blood and tissues, it will be
critical to consider vector ecology and the impact of local human
practices that might increase the risk of individual exposure such
as veterinary investigation of abortions and activities linked with
wildlife hunting and the use of bushmeat.
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